HENRY SCHEIN, INC. Payments for Repurchase of Redeemable Noncontrolling Interest
HENRY SCHEIN, INC. (HSIC) reported Payments for Repurchase of Redeemable Noncontrolling Interest of $42.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest · last filed 2026-08-04
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2026-06-27 was $10.00M, a 150.00% increase year-over-year.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2026-03-28 was $32.00M, a 56.16% decline year-over-year.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2025-12-27 was -$2.00M.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2025-09-27 was $2.00M, a 95.45% decline year-over-year.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2025 was $77.00M, a 69.80% decline from fiscal 2024.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2024 was $255.00M, a 1242.11% increase from fiscal 2023.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2023 was $19.00M, a 50.00% decline from fiscal 2022.
- HENRY SCHEIN, INC. payments for repurchase of redeemable noncontrolling interest for fiscal 2022 was $38.00M, a 36.67% decline from fiscal 2021.
| Period end | Payments for Repurchase of Redeemable Noncontrolling Interest 3 month | Payments for Repurchase of Redeemable Noncontrolling Interest 6 month | Payments for Repurchase of Redeemable Noncontrolling Interest 9 month | Payments for Repurchase of Redeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-27 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $42.00M 10-Q · filed 2026-08-04 | $40.00M derived: sum of 3 quarters · filed 2026-08-04 | $42.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-28 | $32.00M 10-Q · filed 2026-05-05 | $30.00M derived: sum of 2 quarters · filed 2026-05-05 | $32.00M derived: sum of 3 quarters · filed 2026-05-05 | $36.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-27 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $4.00M derived: sum of 3 quarters · filed 2026-08-04 | $77.00M 10-K · filed 2026-02-24 |
| 2025-09-27 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.00M derived: sum of 2 quarters · filed 2026-08-04 | $79.00M 10-Q · filed 2025-11-04 | $79.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-28 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $77.00M 10-Q · filed 2026-08-04 | $77.00M derived: sum of 3 quarters · filed 2026-08-04 | $121.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-29 | $73.00M 10-Q · filed 2026-05-05 | $73.00M derived: sum of 2 quarters · filed 2026-05-05 | $117.00M derived: sum of 3 quarters · filed 2026-05-05 | $234.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $44.00M derived: sum of 2 quarters · filed 2026-02-24 | $161.00M derived: sum of 3 quarters · filed 2026-02-24 | $255.00M 10-K · filed 2026-02-24 |
| 2024-09-28 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $161.00M derived: sum of 2 quarters · filed 2025-11-04 | $255.00M 10-Q · filed 2025-11-04 | $255.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-29 | $117.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $211.00M 10-Q · filed 2025-08-05 | $211.00M derived: sum of 3 quarters · filed 2026-02-24 | $217.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-30 | $94.00M 10-Q · filed 2025-05-05 | $94.00M derived: sum of 2 quarters · filed 2026-02-24 | $100.00M derived: sum of 3 quarters · filed 2026-02-24 | $105.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.00M derived: sum of 2 quarters · filed 2026-02-24 | $11.00M derived: sum of 3 quarters · filed 2026-02-24 | $19.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $11.00M derived: sum of 2 quarters · filed 2024-11-05 | $19.00M 10-Q · filed 2024-11-05 | $24.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-07-01 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $13.00M 10-Q · filed 2024-08-06 | $18.00M derived: sum of 3 quarters · filed 2025-02-25 | $32.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-04-01 | $8.00M 10-Q · filed 2024-05-07 | $13.00M derived: sum of 2 quarters · filed 2025-02-25 | $27.00M derived: sum of 3 quarters · filed 2025-02-25 | $36.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $19.00M derived: sum of 2 quarters · filed 2025-02-25 | $28.00M derived: sum of 3 quarters · filed 2025-02-25 | $38.00M 10-K · filed 2025-02-25 |
| 2022-09-24 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-28 | $23.00M derived: sum of 2 quarters · filed 2023-11-28 | $33.00M 10-Q · filed 2023-11-28 | |
| 2022-06-25 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $19.00M 10-Q · filed 2023-08-07 | ||
| 2022-03-26 | $10.00M 10-Q · filed 2023-05-09 | |||
| 2021-12-25 | $60.00M 10-K · filed 2024-02-28 | |||
| 2020-12-26 | $19.00M 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |